Scilex Holding SCLX
NASDAQ SCLX
$5.20 -0.17 (-3.17%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Net Shares Issued and Repurchased (2020 - 2026)

Scilex Holding (SCLX) posted Net Shares Issued and Repurchased of $10000.0 for Q1 2026, up 1145.33% on a QoQ basis from $803.0 in Q4 2025, and up 66.67% year-over-year from $6000.0 in Q1 2025.

Analysis

Scilex Holding (SCLX) Net Shares Issued and Repurchased (2020 - 2026) Analysis & Trends

Scilex Holding has reported Net Shares Issued and Repurchased for 7 years, with the latest figure at $10000.0 in Q1 2026.

  • On a quarterly basis, Net Shares Issued and Repurchased rose 66.67% year-over-year to $10000.0 in Q1 2026; TTM through Mar 2026 was $10000.0, a 66.67% increase from a year earlier, with the FY2025 full-year figure at $803.0, down 82.21% from the prior year.
  • Net Shares Issued and Repurchased was $10000.0 for Q1 2026 at Scilex Holding, up from $803.0 in the prior quarter.
  • The five-year high for Net Shares Issued and Repurchased was $1.8 million in Q4 2022, with the low at $228.0 in Q1 2024.
  • Average Net Shares Issued and Repurchased over 5 years is $235122.0, with a median of $8000.0 recorded in 2025.
  • The sharpest annual moves came in 2023 and 2025: Net Shares Issued and Repurchased tumbled 99.04% in 2023, then surged 2531.58% in 2025.
  • Over 5 years, Net Shares Issued and Repurchased stood at $1.8 million in 2022, then sank by 99.04% to $17610.0 in 2023, then slumped by 74.36% to $4515.0 in 2024, then slumped by 82.21% to $803.0 in 2025, then surged by 1145.33% to $10000.0 in 2026.
  • The last three Net Shares Issued and Repurchased figures came in at $10000.0 (Q1 2026), $803.0 (Q4 2025), and $6000.0 (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn -
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn -
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -3.07 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -
10 Scilex Holding 38.06 Mn -76.90 Mn 3.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 10,000.00
Dec 31, 2025 803.00
Mar 31, 2025 6,000.00
Dec 31, 2024 4,515.00
Mar 31, 2024 228.00
Dec 31, 2023 17,610.00
Mar 31, 2023 14,820.00
Dec 31, 2022 1.83 Mn
Dec 31, 2021 1.78 Mn
Dec 31, 2020 4.17 Mn